Multiple Sclerosis and Related Disorders

Retinal atrophy as a biomarker in multiple sclerosis 0:54
Retinal atrophy as a biomarker in multiple sclerosis
Christian Cordano • 4 Apr 2022
Rates of neurodegeneration in the retina and cortex across the MS spectrum 5:17
Rates of neurodegeneration in the retina and cortex across the MS spectrum
Christian Cordano • 4 Apr 2022
Vagus nerve stimulation reduces disease in rodent model of MS 7:40
Vagus nerve stimulation reduces disease in rodent model of MS
Yaakov Levine • 22 Jul 2022
Vagus nerve stimulation in MS 3:26
Vagus nerve stimulation in MS
Yaakov Levine • 22 Jul 2022
Benefits of vagus nerve stimulation for MS treatment 3:48
Benefits of vagus nerve stimulation for MS treatment
Yaakov Levine • 22 Jul 2022
Remaining hurdles in managing MS during pregnancy and postpartum 1:06
Remaining hurdles in managing MS during pregnancy and postpartum
Kristen Krysko • 4 Apr 2022
The role of hormonal changes in modulating MS in pregnant women 1:17
The role of hormonal changes in modulating MS in pregnant women
Kristen Krysko • 4 Apr 2022
Challenges in the clinical implementation of novel MS imaging markers 1:16
Challenges in the clinical implementation of novel MS imaging markers
Dejan Jakimovski • 4 Apr 2022
The effect of pregnancy hormones on the symptom severity of multiple sclerosis 1:23
The effect of pregnancy hormones on the symptom severity of multiple sclerosis
Mirla Avila • 12 Apr 2022
Vaginal estriol improves quality of life for patients with relapsing/remitting multiple sclerosis 3:03
Vaginal estriol improves quality of life for patients with relapsing/remitting multiple sclerosis
Mirla Avila • 12 Apr 2022
AZ257: Novel dopamine transporter receptor for the treatment of MS 1:58
AZ257: Novel dopamine transporter receptor for the treatment of MS
Mirla Avila • 12 Apr 2022
Current imaging techniques in predicting MS outcomes 2:35
Current imaging techniques in predicting MS outcomes
Dejan Jakimovski • 4 Apr 2022
Differential cerebrovascular reactivity in patients with MS 1:33
Differential cerebrovascular reactivity in patients with MS
Dejan Jakimovski • 4 Apr 2022
Rehabilitation combined with excitatory transcranial magnetic stimulation for patients with MS 6:23
Rehabilitation combined with excitatory transcranial magnetic stimulation for patients with MS
Letizia Leocani • 4 Apr 2022
Racial disparities among patients with NMOSD 1:46
Racial disparities among patients with NMOSD
Mirla Avila • 12 Apr 2022
The potential of retinal imaging for monitoring patients with MS 3:47
The potential of retinal imaging for monitoring patients with MS
Letizia Leocani • 4 Apr 2022
The content of VJNeurology is intended for healthcare professionals